These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2833543)

  • 41. Treatment-emergent depression with antidepressants in panic disorder.
    Aronson TA
    Compr Psychiatry; 1989; 30(3):267-71. PubMed ID: 2731426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants.
    Noyes R; Garvey MJ; Cook BL
    J Affect Disord; 1989; 16(2-3):249-57. PubMed ID: 2522124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Panic disorder: response to sodium lactate and treatment with antidepressants.
    Rifkin A; Siris SG
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):33-8. PubMed ID: 3887490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The treatment of pathological panic states with propranolol.
    Heiser JF; Defrancisco D
    Am J Psychiatry; 1976 Dec; 133(12):1389-94. PubMed ID: 984238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J; Vallejo J
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects.
    Nyström C; Hällström T
    Acta Psychiatr Scand; 1985 Jul; 72(1):6-15. PubMed ID: 2930998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in the drug treatment of anxiety disorders.
    Pohl R; Rainey JM; Gershon S
    Psychopathology; 1984; 17 Suppl 1():6-14. PubMed ID: 6369369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia.
    Ghoneim MM; Hinrichs JV; Noyes R; Anderson DJ
    Neuropsychobiology; 1984; 11(4):229-35. PubMed ID: 6387529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluoxetine in panic disorder patients with imipramine-associated weight gain.
    Brady K; Zarzar M; Lydiard RB
    J Clin Psychopharmacol; 1989 Feb; 9(1):66-7. PubMed ID: 2785123
    [No Abstract]   [Full Text] [Related]  

  • 51. L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS
    Br J Psychiatry; 1985 Jul; 147():16-22. PubMed ID: 3933601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 53. Imipramine in the treatment of panic disorder and its complications.
    Liebowitz MR
    Psychiatr Clin North Am; 1985 Mar; 8(1):37-47. PubMed ID: 3887338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
    Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
    Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The dexamethasone suppression test in panic disorder and agoraphobia.
    Curtis GC; Cameron OG; Nesse RM
    Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
    Kasper S; Dötsch M; Kick H; Vieira A; Möller HJ
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):13-21. PubMed ID: 8471827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular effects of fluvoxamine and maprotiline in depressed patients.
    Hewer W; Rost W; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):1-6. PubMed ID: 8773212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.